Advanced Therapies Europe 2020

29TH - 30TH SEPTEMBER 2020



Claire Roddie

Claire Roddie

Consultant Haematologist and Honorary Senior Lecturer in Haematology, University College London

Claire Roddie is a Consultant Haematologist and Honorary Senior Lecturer in Haematology at University College London with a particular interest in Chimeric Antigen Receptor (CAR) T-cells for Cancer. She completed a PhD in Cellular Immunotherapy at UCL in the laboratory of Professor Karl Peggs and subsequently undertook a Clinician Scientist post in Dr Martin Pule’s Laboratory to work on the UCL CAR T-cell program.  Her current role involves pre-clinical development of novel CAR projects, GMP CAR T-cell manufacture and Clinical Trial design for academic CAR T-cell studies at UCL.  She is also responsible for the development of a clinical service at UCLH to support patients recruited to CAR T-cell studies and those receiving CAR T on the NHS. 

  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd